Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
panlongqi
- Development stage
- Phase 3
- Lead developer
- Panlong Pharmaceutical
- Administration
- Oral
01
Overview
Panlongqi is a traditional Chinese medicine (TCM) compound prescription used for the treatment of osteoarthritis, rheumatoid arthritis, and bone injuries. It is most commonly available as the Panlongqi Tablet (Panlongqi Pian), which is manufactured by Shaanxi Panlong Pharmaceutical Group. The formula consists of 29 medicinal herbs, including *Bergenia purpurascens* (from which it derives its name), *Panax notoginseng*, *Carthamus tinctorius*, and *Angelica sinensis*. Its pharmacological actions include anti-inflammatory, analgesic, and microcirculation-improving effects, achieved through the regulation of inflammatory mediators such as TNF-α and IL-1β. It is clinically indicated for relieving joint pain, swelling, and functional limitations in patients with knee osteoarthritis. A Phase 3 clinical trial sponsored by Guang'anmen Hospital has investigated its efficacy and safety in this population.
- Brand names
- Panlongqi TabletPanlongqi Pian
- Other names
- Panlongqi
02
Targets
IL1B (Interleukin-1 beta)PGHS-1 (Prostaglandin G/H Synthase 1)COXTNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on panlongqi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on panlongqi.